Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)

被引：0
|
作者：
Antonia, S. J. [1 ]
Wu, N. [2 ]
Ge, W. [2 ]
Pouliot, J-F. [2 ]
Dietz, H. [1 ]
Jalbert, J. [2 ]
Quek, R. G. [2 ]
Harnett, J. [2 ]
机构：
[1] Duke Univ, Ctr Canc Immunotherapy, Sch Med, Durham, NC USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103P
引用
收藏
页码：S1419 / S1420
页数：2
相关论文
共 50 条
  • [31] Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)
    Gadgeel, S. M.
    Zhang, Q.
    Lin, H.
    Fajardo, O.
    Trinh, H.
    Arndorfer, S.
    Kong, S.
    Rahman, A.
    Li, S.
    Archer, V. R.
    Gainor, J. F.
    ANNALS OF ONCOLOGY, 2023, 34
  • [32] Real-World Efficacy of First-Line Pembrolizumab in Patients with Advanced PD-L1 High Non-Small Cell Lung Cancer in Argentina
    Kuzminin, A.
    Minatta, N.
    Bluthgen, M.
    Rizzo, M.
    Naveira, M.
    Wainsztein, V.
    Lupinacci, L.
    Rizzi, M.
    Faura, M.
    Perfetti, A.
    Recondo, G., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S589 - S590
  • [33] Shifting treatment landscape and overall survival by PD-L1 expression level among patients with advanced non-small cell lung cancer (ansclc)
    Ge, Wenzhen
    Dietz, Hilary
    Wu, Ning
    Quek, Ruben G. W.
    Pouliot, Jean-Francois
    Antonia, Scott
    Jalbert, Jessica
    Harnett, James
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 296 - 296
  • [34] A real-world study of PD-L1 testing patterns and PD-1/PD-L1 inhibitor therapy in patients with metastatic non-small cell lung cancer: An analysis of the Sotiria Hospital lung cancer registry
    Charpidou, Andriani
    Syrigos, Nikolaos K.
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Tsagouli, Sofia
    Burke, Thomas
    Spanoudi, Filio
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Gkiozos, Ioannis
    PNEUMON, 2024,
  • [35] REAL-WORLD TREATMENT PATTERNS AMONG ADULT PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE US
    Chen, Y.
    Carlson, A.
    VALUE IN HEALTH, 2024, 27 (06) : S387 - S388
  • [36] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Hozefa A. Divan
    Marisa A. Bittoni
    Ashok Krishna
    David P. Carbone
    BMC Cancer, 24
  • [37] Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
    Divan, Hozefa A.
    Bittoni, Marisa A.
    Krishna, Ashok
    Carbone, David P.
    BMC CANCER, 2024, 24 (01)
  • [38] Identification and use of treatment (tx) options in patients (pts) with advanced non-small cell lung cancer (aNSCLC) after comprehensive genomic profiling (CGP): A real-world study.
    Mascaux, Celine
    Bubendorf, Lukas
    Barlesi, Fabrice
    Clendening, James W.
    Zhang, Qing
    Mace, Kieran
    Gondos, Adam
    Foser, Stefan
    Wang, Lisa I.
    Paz-Ares, Luis G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
    Xie, Mingying
    Li, Na
    Xu, Xiaoling
    Xu, Yanjun
    Li, Hui
    Zhu, Liang
    Sheng, Jiamin
    Zhou, Zichao
    Fan, Yun
    CANCERS, 2022, 14 (17)
  • [40] Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer
    Zhou, Zi-Chao
    Chen, Kai-Yan
    Li, Na
    Xie, Ming-Ying
    Sheng, Jia-Min
    Fan, Yun
    Huang, Zhi-Yu
    THORACIC CANCER, 2022, 13 (16) : 2291 - 2300
12345